Physician profile
Timothy Leach
NPI 1396746491
$51,575.27
in general payments reported to CMS, 2019-2025
12 companies · $524 in 2025
The $524 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $2,903 · 2021: $2,552 · 2022: $20K · 2023: $2,915 · 2024: $4,276 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,500 · Food and Beverage: $1,813 · Consulting Fee: $1,500 · Travel and Lodging: $877 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,500.00 |
| Food and Beverage | $1,813.36 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $876.51 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $25,472.29 | 2022-2024 | Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22,735.09 | 2019-2021 | |
| Alcon Vision LLC | $1,429.35 | 2019-2024 | Total30 |
| Coopervision INC. | $618.59 | 2019-2024 | Cvi Contact Lens, Myday Contact Lens |
| Rxsight INC | $481.31 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Vision Care, INC. | $378.00 | 2019-2025 | |
| Abbvie INC. | $177.58 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $125.00 | 2025 | Veritas Vision System, Tecnis Simplicity, Tecnis Iol |
| Biotissue Holdings INC. | $106.08 | 2019-2025 | |
| Allergan, INC. | $21.26 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $16.38 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $14.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.